Read here for an analysis of GSUS ETF's performance, strengths, and weaknesses vs. IVV. See more on its growth edge and why ...

Goldman Sachs upgraded Danaher (DHR) to Buy from Neutral with a $260 price target Since the firm’s downgrade at the end of 2023, FY25 ...

Nike (NKE) is expected to report results on its fiscal third quarter on Thursday, March 20, with a conference call scheduled for 5:00 pm EDT.

Consequently, the Wall Street brokerage bumped up its rating on the Czech Republic to "neutral" from "underweight" and kept ...

Cloud-based Elite platform to roll out to Roche's laboratory network across 50+ countries and a target 1,000 installations over five years. BASEL, Switzerland, March 18, 2025 /PRNewswire/ ...

The rally that propelled the S&P 500 to record highs is fading, leading Goldman Sachs to lower its year-end target for the ...

Ameriprise Financial is a strong Buy for long-term investors, with stellar Q4 2024 results, 19 years of dividend growth, and ...

Also, the pace of EPS or earning per share downgrade cycle has moderated. This means analysts while they are reducing their profit estimates for companies, nevertheless, they are doing it a ...

The Goldman Sachs Group Inc's intrinsic value estimated by Discounted Earnings model are arrived at by following assumptions and steps. GuruFocus DCF calculator uses EPS without NRI as the default ...

Goldman Sachs has seen booming business from its outposts in Dallas and Salt Lake City, and it's hoping to corral more of its staff there — whether they like it or not. The financial giant is ...

In its latest monthly data, Goldman Sachs also lowered target prices for Indian pharmaceutical companies by 12%. As per the latest monthly economic data, trends on input costs, and market share ...